The Pakistani non-life insurer generated positive underwriting and investment results, producing a 16.3% weighted average return on equity between 2021 and 2025.
Risk-adjusted capitalisation is expected to remain at its strongest level, but the agency noted that volatile cover and a small net premium base have kept underwriting profitability subdued over the past...
The transaction, announced on 31 July, remained subject to closing conditions and regulatory and exchange approvals, with completion expected during August.
The Taiwan reinsurer’s domestic life book continued to expand, while retained profit increased adjusted capital and surplus into the first quarter of 2026.
The insurer registered a 102.5% combined ratio in 2025, though AM Best expects growth in Korea Interests Abroad and affiliate business to support future results.
